PDL BioPharma (PDLI)
PDL BioPharma Accounts Receivable
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
PDLI Accounts Receivable Range, Past 5 Years
| Minimum | 0.15M | Jun 2009 |
| Maximum | 13.50M | Dec 2008 |
| Average | 3.262M |
About Accounts Receivable
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
YCharts takes accounts receivable from the balance sheet of a company. It is reported net of allowance for bad debts.
Learn More
You may also be interested in these PDLI related companies
PDLI News
Stocks trading ex-dividend one week from today: http://stks.co/40f2 $BLK $BEBE $BOX $CEC $LEA $LPS $PDLI $PX ...
about 3 days ago by DynamicDividend
about 3 days ago by DynamicDividend
$PDLI http://stks.co/408f top of expanding wedge, over 6.60 BO w/ 7.10 target initally
about 4 days ago by harmongreg
about 4 days ago by harmongreg
$PDLI http://stks.co/3wcN approaching breakout point on a volume spike... http://stks.co/3wcO
about 9 days ago by TraderHR
about 9 days ago by TraderHR
@Fibline Nice list yessir, liking $SLXP from last week, bought $ARIA today, like the divy on $PDLI, hope it breaks up
about 17 days ago by harmongreg
about 17 days ago by harmongreg
@Legacy_Trades you still like $PDLI here? TA looking up, but would appreciate your FA view.
about 21 days ago by gtlackey
about 21 days ago by gtlackey
Watchlist 5/7.Careful tday but following charts look ready for a small run.$KGJI,$AFFX,$GEOY,$NAVG,$PDLI,$VNET.Look for intraday weakness.
about 25 days ago by traderNC
about 25 days ago by traderNC
PDL BioPharma's CEO Discusses Q1 2012 Results - Earnings Call Transcript
May 03, 6:52PM Seeking Alpha
May 03, 6:52PM Seeking Alpha
Listen to $PDLI Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3eza
about 28 days ago by earningscast
about 28 days ago by earningscast
PDL BioPharma to Announce First Quarter 2012 Financial Results on May 3, 2012
Apr 27, 5:56PM PR Newswire
Apr 27, 5:56PM PR Newswire
PDL BioPharma Provides First Quarter 2012 Royalty Revenue Guidance of $77 Million
Mar 08, 4:02PM PR Newswire
Mar 08, 4:02PM PR Newswire
$PDLI forms bearish "Double Top" chart pattern. http://stks.co/2haG
about 86 days ago by RecogniaEvents
about 86 days ago by RecogniaEvents
PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes
Mar 05, 4:02PM PR Newswire
Mar 05, 4:02PM PR Newswire
7 High Profitable Healthcare Dividend Stocks With Fantastic Yields + http://stks.co/2dw4 + $PDLI $AZN $PMD $GSK $BMY $NVO $SHPGY
about 91 days ago by DividendYield
about 91 days ago by DividendYield
PDL BioPharma's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Feb 23, 10:46PM Seeking Alpha
Feb 23, 10:46PM Seeking Alpha
Listen to $PDLI Q4 2011 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2XOK
about 98 days ago by earningscast
about 98 days ago by earningscast
$PDLI Reports Q4 EPS $0.24 vs $0.24 Est; Revenues $72.8M vs $72.85M Est
about 98 days ago by Benzinga
about 98 days ago by Benzinga
PDL BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results
Feb 23, 4:00PM PR Newswire
Feb 23, 4:00PM PR Newswire
PDL BioPharma to Announce Fourth Quarter and Full Year 2011 Financial Results on February 23, 2012
Feb 16, 7:00AM PR Newswire
Feb 16, 7:00AM PR Newswire
Seth Klarman's Baupost Group drastically reduces PDL BioPharma $PDLI position http://stks.co/2LmR
about 111 days ago by marketfolly
about 111 days ago by marketfolly
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PDLI | 6.47 | -0.01 | -0.15% | 906.42M |
| PDII | 7.41 | -0.05 | -0.67% | 111.08M |
| PDFS | 8.84 | +0.10 | +1.14% | 248.74M |
| PDEX | 2.00 | +0.15 | +8.11% | 6.54M |
| ROG | 40.26 | +0.26 | +0.65% | 650.80M |
| RODM | 0.50 | -0.08 | -13.79% | 19.95M |
| ROCM | 9.95 | +0.00 | +0.00% | 120.40M |
| ROCK | 10.24 | +0.00 | +0.00% | 312.73M |
| ROC | 48.40 | -0.43 | -0.88% | 3.778B |
| RNWKD | 8.72 | -0.09 | -1.02% |